Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Mouth, Edentulous D009066 1 associated lipids
Anthrax D000881 1 associated lipids
Egg Hypersensitivity D021181 1 associated lipids
Leukostasis D018921 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Migraine without Aura D020326 1 associated lipids
Ileitis D007079 2 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Peanut Hypersensitivity D021183 2 associated lipids
Multiple Trauma D009104 2 associated lipids
Amnesia, Anterograde D020324 2 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Dementia, Multi-Infarct D015161 2 associated lipids
Capillary Leak Syndrome D019559 2 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Hemorrhagic Fever, American D006478 2 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Extravasation of Diagnostic and Therapeutic Materials D005119 3 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Dyslexia D004410 3 associated lipids
Leukemia, Eosinophilic, Acute D015472 3 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Toxemia D014115 3 associated lipids
Contracture D003286 3 associated lipids
Bronchial Diseases D001982 3 associated lipids
Pneumonia, Pneumococcal D011018 3 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Ileal Diseases D007077 3 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Brain Injuries D001930 4 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Thrombasthenia D013915 4 associated lipids
Thrombocytosis D013922 4 associated lipids
Cluster Headache D003027 4 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Hyperuricemia D033461 4 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Viremia D014766 4 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Zang BX et al. [Inhibitory effect of kaempferol against binding of platelet activating factor to its receptor]. 2004 Zhongguo Zhong Yao Za Zhi pmid:15506296
Bankers-Fulbright JL et al. Platelet-activating factor stimulates cytoplasmic alkalinization and granule acidification in human eosinophils. 2004 J. Cell. Sci. pmid:15507482
Gambero A et al. Signalling pathways regulating human neutrophil migration induced by secretory phospholipases A2. 2004 Toxicon pmid:15450921
Hla T Prostaglandins & other lipid mediators: a new phase, a new team. 2004 Prostaglandins Other Lipid Mediat. pmid:15165026
Ruan Z et al. Effects of platelet-activating factor and thromboxane A2 on isolated perfused guinea pig liver. 2004 Prostaglandins Other Lipid Mediat. pmid:15165033
Amer MD et al. Platelet-activating factor concentration in the stool of human newborns: effects of enteral feeding and neonatal necrotizing enterocolitis. 2004 Biol. Neonate pmid:14646336
Cinamon G et al. Chemoattractant signals and beta 2 integrin occupancy at apical endothelial contacts combine with shear stress signals to promote transendothelial neutrophil migration. 2004 J. Immunol. pmid:15585851
Bender A et al. Molecular surface point environments for virtual screening and the elucidation of binding patterns (MOLPRINT 3D). 2004 J. Med. Chem. pmid:15588092
Bate C et al. Phospholipase A2 inhibitors or platelet-activating factor antagonists prevent prion replication. 2004 J. Biol. Chem. pmid:15210691
Jakubowski A et al. Involvement of platelet activating factor in immediate heart response to lipopolysaccharide. 2004 J. Physiol. Pharmacol. pmid:15213362
Taylor KE Familial cancer and developmental dyslexia: an observational pilot study. 2004 Dev Med Child Neurol pmid:14974637
Seo KH et al. Essential role for platelet-activating factor-induced NF-kappaB activation in macrophage-derived angiogenesis. 2004 Eur. J. Immunol. pmid:15259010
Zhu P et al. Interplay among platelet-activating factor, oxidative stress, and group I metabotropic glutamate receptors modulates neuronal survival. 2004 J. Neurosci. Res. pmid:15264222
Lu DP et al. Trophic signals acting via phosphatidylinositol-3 kinase are required for normal pre-implantation mouse embryo development. 2004 J. Cell. Sci. pmid:15020683
Sarchielli P et al. Platelet-activating factor (PAF) in internal jugular venous blood of migraine without aura patients assessed during migraine attacks. 2004 Cephalalgia pmid:15265050
Ziche M Absence of PAF actions increases angiogenesis. 2004 Br. J. Pharmacol. pmid:15023858
Roudebush WE et al. Platelet-activating factor significantly enhances intrauterine insemination pregnancy rates in non-male factor infertility. 2004 Fertil. Steril. pmid:15236989
Ferreira MA et al. Sponge-induced angiogenesis and inflammation in PAF receptor-deficient mice (PAFR-KO). 2004 Br. J. Pharmacol. pmid:15023865
Alloatti G et al. Phosphoinositide 3-kinase gamma: kinase-dependent and -independent activities in cardiovascular function and disease. 2004 Biochem. Soc. Trans. pmid:15046613
Shio MT et al. PAF is involved in the Mycoplasma arthritidis superantigen-triggering pathway for iNOS and COX-2 expression in murine peritoneal cells. 2004 Exp. Cell Res. pmid:15242784
Naoki K et al. PAF responsiveness in Japanese subjects with plasma PAF acetylhydrolase deficiency. 2004 Biochem. Biophys. Res. Commun. pmid:15047169
Sugatani J et al. Tea polyphenols inhibit acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation. 2004 Int. Arch. Allergy Immunol. pmid:15051936
Martin C et al. Pressor responses to platelet-activating factor and thromboxane are mediated by Rho-kinase. 2004 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:15064228
Alfaro V Role of histamine and platelet-activating factor in allergic rhinitis. 2004 J. Physiol. Biochem. pmid:15457928
Baker KE and Curtis MJ Left regional cardiac perfusion in vitro with platelet-activating factor, norepinephrine and K+ reveals that ischaemic arrhythmias are caused by independent effects of endogenous "mediators" facilitated by interactions, and moderated by paradoxical antagonism. 2004 Br. J. Pharmacol. pmid:15066909
Uemura K et al. Superoxide production from human polymorphonuclear leukocytes by human mannan-binding protein (MBP). 2004 Glycoconj. J. pmid:15467404
Victorino GP et al. Modulation of microvascular hydraulic permeability by platelet-activating factor. 2004 J Trauma pmid:14960983
Ko HH et al. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation. 2004 J. Pharm. Pharmacol. pmid:15482650
Ewer AK et al. The role of platelet activating factor in a neonatal piglet model of necrotising enterocolitis. 2004 Gut pmid:14724152
Angeli V et al. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. 2004 Immunity pmid:15485633
Tai H et al. TMVA, a snake C-type lectin-like protein from Trimeresurus mucrosquamatus venom, activates platelet via GPIb. 2004 Toxicon pmid:15501291
McDonagh PF et al. Chronic expression of platelet adhesion proteins is associated with severe ischemic heart disease in type 2 diabetic patients: Chronic platelet activation in diabetic heart patients. 2003 Sep-Oct J. Diabetes Complicat. pmid:12954156
Kerek M et al. Effects of recombinant platelet activating factor acetylhydrolase in obstructive jaundice. 2003 Jul-Aug Hepatogastroenterology pmid:12845989
Baltás E et al. Platelet-activating factor antagonist WEB 2086 inhibits ultraviolet-B radiation-induced dermatitis in the human skin. 2003 Jul-Aug Skin Pharmacol. Appl. Skin Physiol. pmid:12784066
Hsueh W et al. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. 2003 Jan-Feb Pediatr. Dev. Pathol. pmid:12424605
Diez-Fraile A et al. Analysis of selective mobilization of L-selectin and Mac-1 reservoirs in bovine neutrophils and eosinophils. 2003 Jan-Feb Vet. Res. pmid:12588684
Zhang GQ et al. [The effects of milkvetch and memantain on the synthesis of cerebral PAF in neonatal rats with hypoxic-ischemic reperfusion]. 2003 Zhonghua Er Ke Za Zhi pmid:14751060
Mayerle J et al. [Conservative treatment of acute pancreatitis]. 2003 Med. Klin. (Munich) pmid:14685675
Tokuoka SM et al. Involvement of platelet-activating factor and LIS1 in neuronal migration. 2003 Eur. J. Neurosci. pmid:12911752
Lupia E et al. Intra-plaque production of platelet-activating factor correlates with neoangiogenesis in human carotid atherosclerotic lesions. 2003 Int. J. Mol. Med. pmid:12883648
Handa RK et al. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo. 2003 Kidney Blood Press. Res. pmid:12886044
Witko-Sarsat V et al. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. 2003 Kidney Int. pmid:12787398
Elovitz MA et al. A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. 2003 Am. J. Pathol. pmid:14578208
Slomiany BL and Slomiany A Platelet-activating factor modulates gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide. 2003 Biochem. Biophys. Res. Commun. pmid:12788098
Kogure K et al. Temporary membrane distortion of vascular smooth muscle cells is responsible for their apoptosis induced by platelet-activating factor-like oxidized phospholipids and their degradation product, lysophosphatidylcholine. 2003 Chem. Phys. Lipids pmid:14580708
Schuster DP et al. Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial. 2003 Crit. Care Med. pmid:12794395
Rabinovici R Platelet activating factor inhibition in sepsis: the end? 2003 Crit. Care Med. pmid:12794432
Bernatchez PN et al. Sphingosine 1-phosphate effect on endothelial cell PAF synthesis: role in cellular migration. 2003 J. Cell. Biochem. pmid:14587028
Kordan W et al. Functions of platelet activating factor (PAF) in mammalian reproductive processes: a review. 2003 Pol J Vet Sci pmid:12675470
Loucks EB et al. Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart. 2003 Can J Cardiol pmid:12677282